These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. Totoritis MC; Tan EM; McNally EM; Rubin RL N Engl J Med; 1988 Jun; 318(22):1431-6. PubMed ID: 3259287 [TBL] [Abstract][Full Text] [Related]
6. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. Woosley RL; Drayer DE; Reidenberg MM; Nies AS; Carr K; Oates JA N Engl J Med; 1978 May; 298(21):1157-9. PubMed ID: 306574 [TBL] [Abstract][Full Text] [Related]
7. A systemic lupus erythematosus-like syndrome induced by procainamide. Zeide MS; Wiesel S; Terry R; Stein D Clin Orthop Relat Res; 1978; (134):290-2. PubMed ID: 729256 [TBL] [Abstract][Full Text] [Related]
9. Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes. Whittle TS; Ainsworth SK Arch Pathol Lab Med; 1976 Sep; 100(9):469-74. PubMed ID: 782399 [TBL] [Abstract][Full Text] [Related]
10. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. Rubin RL; Burlingame RW; Arnott JE; Totoritis MC; McNally EM; Johnson AD J Immunol; 1995 Mar; 154(5):2483-93. PubMed ID: 7868914 [TBL] [Abstract][Full Text] [Related]
18. Effects of long-term treatment with procaine amide. A prospective study with special regard to ANF and SLE in fast and slow acetylators. Henningsen NC; Cederberg A; Hanson A; Johansson BW Acta Med Scand; 1975 Dec; 198(6):475-82. PubMed ID: 55060 [TBL] [Abstract][Full Text] [Related]
19. Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature. Foucar E; Erickson DG; Tung KS J Clin Lab Immunol; 1979 Apr; 2(1):79-84. PubMed ID: 95811 [TBL] [Abstract][Full Text] [Related]